Eintrag weiter verarbeiten
Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis.
Gespeichert in:
| Zeitschriftentitel: | Journal of Clinical Oncology |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , , , , , , , , , |
| In: | Journal of Clinical Oncology, 34, 2016, 4_suppl, S. 326-326 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Society of Clinical Oncology (ASCO)
|
| Schlagwörter: |
| author_facet |
Mogal, Harveshp Dodson, Rebecca Fino, Nora Ethun, Cecilia Grace Pawlik, Timothy M. Poultsides, George A. Tran, Thuy Idrees, Kamran Fields, Ryan C. Jin, Linda Weber, Sharon M. Salem, Ahmed I. Martin, Robert C. G. Scoggins, Charles Raben Schmidt, Carl Richard Beal, Eliza W Hatzaras, Ioannis Shenoy, Rivfka Maithel, Shishir Kumar Shen, Perry Mogal, Harveshp Dodson, Rebecca Fino, Nora Ethun, Cecilia Grace Pawlik, Timothy M. Poultsides, George A. Tran, Thuy Idrees, Kamran Fields, Ryan C. Jin, Linda Weber, Sharon M. Salem, Ahmed I. Martin, Robert C. G. Scoggins, Charles Raben Schmidt, Carl Richard Beal, Eliza W Hatzaras, Ioannis Shenoy, Rivfka Maithel, Shishir Kumar Shen, Perry |
|---|---|
| author |
Mogal, Harveshp Dodson, Rebecca Fino, Nora Ethun, Cecilia Grace Pawlik, Timothy M. Poultsides, George A. Tran, Thuy Idrees, Kamran Fields, Ryan C. Jin, Linda Weber, Sharon M. Salem, Ahmed I. Martin, Robert C. G. Scoggins, Charles Raben Schmidt, Carl Richard Beal, Eliza W Hatzaras, Ioannis Shenoy, Rivfka Maithel, Shishir Kumar Shen, Perry |
| spellingShingle |
Mogal, Harveshp Dodson, Rebecca Fino, Nora Ethun, Cecilia Grace Pawlik, Timothy M. Poultsides, George A. Tran, Thuy Idrees, Kamran Fields, Ryan C. Jin, Linda Weber, Sharon M. Salem, Ahmed I. Martin, Robert C. G. Scoggins, Charles Raben Schmidt, Carl Richard Beal, Eliza W Hatzaras, Ioannis Shenoy, Rivfka Maithel, Shishir Kumar Shen, Perry Journal of Clinical Oncology Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. Cancer Research Oncology |
| author_sort |
mogal, harveshp |
| spelling |
Mogal, Harveshp Dodson, Rebecca Fino, Nora Ethun, Cecilia Grace Pawlik, Timothy M. Poultsides, George A. Tran, Thuy Idrees, Kamran Fields, Ryan C. Jin, Linda Weber, Sharon M. Salem, Ahmed I. Martin, Robert C. G. Scoggins, Charles Raben Schmidt, Carl Richard Beal, Eliza W Hatzaras, Ioannis Shenoy, Rivfka Maithel, Shishir Kumar Shen, Perry 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2016.34.4_suppl.326 <jats:p> 326 </jats:p><jats:p> Background: Perioperative and long-term outcomes of patients with Hilar cholangiocarcinoma (HC) and preoperative hyperbilirubinemia have not been clearly defined. Methods: Patients with HC undergoing hepatectomy with a complete (R0/R1) resection between 2000 and 2014 were identified within a 10-institution prospectively maintained database. Using receiver operating characteristic curves from logistic regression models, a peak bilirubin cutoff point that minimized the difference between the sensitivity and specificity, was determined. Factors affecting perioperative complications were estimated using logistic regression. Results: 191 of 328 (58.2%) patients who underwent complete resection with a hepatectomy, with available preoperative bilirubin data were analyzed. 37.2% (n = 71) had bilirubin > 7.9. Patients with higher preoperative bilirubin were more likely to have a higher CA 19-9 (1776±3721.5 vs 302.1±518.6, p = 0.0006), more comorbidities (1.6±0.8 vs 1.4±0.9; p = 0.002), preoperative biliary drainage (PBD) (91.4% vs 75.6%, p = 0.007), positive lymph nodes (48.5% vs 31.5%, p = 0.025) and perioperative death (14.5% vs 5.2%, p = 0.0292). Multivariate analysis identified PBD (OR 3.2, CI 1.4-7.5; p = 0.008) and smoking (OR 2.3, CI 1.2-4.4; p = 0.016) to be independent predictors of any and major complications. Peak bilirubin > 7.9 (OR 3.1, CI 1.1-8.9; p = 0.04) and preoperative systemic sepsis (PSS) (OR 5.0, CI 1.2-21.5; p = 0.03) were associated with increased risk of postoperative mortality. However, on multivariate analysis only PSS was significant (OR 14.4, CI 2.2-93.9; p = 0.005); 5/13 (23.1%) of patients with PSS died within 30 days after surgery. Conclusions: PSS portends increased operative mortality in HC patients undergoing hepatectomy, independent of preoperative peak bilirubin levels. Prevention and aggressive treatment of PSS should be the priority in the preoperative optimization of these patients. </jats:p> Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. Journal of Clinical Oncology |
| doi_str_mv |
10.1200/jco.2016.34.4_suppl.326 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNi4zNC40X3N1cHBsLjMyNg |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNi4zNC40X3N1cHBsLjMyNg |
| institution |
DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 |
| imprint |
American Society of Clinical Oncology (ASCO), 2016 |
| imprint_str_mv |
American Society of Clinical Oncology (ASCO), 2016 |
| issn |
0732-183X 1527-7755 |
| issn_str_mv |
0732-183X 1527-7755 |
| language |
English |
| mega_collection |
American Society of Clinical Oncology (ASCO) (CrossRef) |
| match_str |
mogal2016effectofpreoperativebilirubinonoutcomesofcompletelyresectedhilarcholangiocarcinomaamultiinstitutionalanalysis |
| publishDateSort |
2016 |
| publisher |
American Society of Clinical Oncology (ASCO) |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Clinical Oncology |
| source_id |
49 |
| title |
Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. |
| title_unstemmed |
Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. |
| title_full |
Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. |
| title_fullStr |
Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. |
| title_full_unstemmed |
Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. |
| title_short |
Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. |
| title_sort |
effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: a multi-institutional analysis. |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1200/jco.2016.34.4_suppl.326 |
| publishDate |
2016 |
| physical |
326-326 |
| description |
<jats:p> 326 </jats:p><jats:p> Background: Perioperative and long-term outcomes of patients with Hilar cholangiocarcinoma (HC) and preoperative hyperbilirubinemia have not been clearly defined. Methods: Patients with HC undergoing hepatectomy with a complete (R0/R1) resection between 2000 and 2014 were identified within a 10-institution prospectively maintained database. Using receiver operating characteristic curves from logistic regression models, a peak bilirubin cutoff point that minimized the difference between the sensitivity and specificity, was determined. Factors affecting perioperative complications were estimated using logistic regression. Results: 191 of 328 (58.2%) patients who underwent complete resection with a hepatectomy, with available preoperative bilirubin data were analyzed. 37.2% (n = 71) had bilirubin > 7.9. Patients with higher preoperative bilirubin were more likely to have a higher CA 19-9 (1776±3721.5 vs 302.1±518.6, p = 0.0006), more comorbidities (1.6±0.8 vs 1.4±0.9; p = 0.002), preoperative biliary drainage (PBD) (91.4% vs 75.6%, p = 0.007), positive lymph nodes (48.5% vs 31.5%, p = 0.025) and perioperative death (14.5% vs 5.2%, p = 0.0292). Multivariate analysis identified PBD (OR 3.2, CI 1.4-7.5; p = 0.008) and smoking (OR 2.3, CI 1.2-4.4; p = 0.016) to be independent predictors of any and major complications. Peak bilirubin > 7.9 (OR 3.1, CI 1.1-8.9; p = 0.04) and preoperative systemic sepsis (PSS) (OR 5.0, CI 1.2-21.5; p = 0.03) were associated with increased risk of postoperative mortality. However, on multivariate analysis only PSS was significant (OR 14.4, CI 2.2-93.9; p = 0.005); 5/13 (23.1%) of patients with PSS died within 30 days after surgery. Conclusions: PSS portends increased operative mortality in HC patients undergoing hepatectomy, independent of preoperative peak bilirubin levels. Prevention and aggressive treatment of PSS should be the priority in the preoperative optimization of these patients. </jats:p> |
| container_issue |
4_suppl |
| container_start_page |
326 |
| container_title |
Journal of Clinical Oncology |
| container_volume |
34 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792328285997236225 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T12:50:52.614Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Effect+of+preoperative+bilirubin+on+outcomes+of+completely+resected+hilar+cholangiocarcinoma%3A+A+multi-institutional+analysis.&rft.date=2016-02-01&genre=article&issn=1527-7755&volume=34&issue=4_suppl&spage=326&epage=326&pages=326-326&jtitle=Journal+of+Clinical+Oncology&atitle=Effect+of+preoperative+bilirubin+on+outcomes+of+completely+resected+hilar+cholangiocarcinoma%3A+A+multi-institutional+analysis.&aulast=Shen&aufirst=Perry&rft_id=info%3Adoi%2F10.1200%2Fjco.2016.34.4_suppl.326&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792328285997236225 |
| author | Mogal, Harveshp, Dodson, Rebecca, Fino, Nora, Ethun, Cecilia Grace, Pawlik, Timothy M., Poultsides, George A., Tran, Thuy, Idrees, Kamran, Fields, Ryan C., Jin, Linda, Weber, Sharon M., Salem, Ahmed I., Martin, Robert C. G., Scoggins, Charles Raben, Schmidt, Carl Richard, Beal, Eliza W, Hatzaras, Ioannis, Shenoy, Rivfka, Maithel, Shishir Kumar, Shen, Perry |
| author_facet | Mogal, Harveshp, Dodson, Rebecca, Fino, Nora, Ethun, Cecilia Grace, Pawlik, Timothy M., Poultsides, George A., Tran, Thuy, Idrees, Kamran, Fields, Ryan C., Jin, Linda, Weber, Sharon M., Salem, Ahmed I., Martin, Robert C. G., Scoggins, Charles Raben, Schmidt, Carl Richard, Beal, Eliza W, Hatzaras, Ioannis, Shenoy, Rivfka, Maithel, Shishir Kumar, Shen, Perry, Mogal, Harveshp, Dodson, Rebecca, Fino, Nora, Ethun, Cecilia Grace, Pawlik, Timothy M., Poultsides, George A., Tran, Thuy, Idrees, Kamran, Fields, Ryan C., Jin, Linda, Weber, Sharon M., Salem, Ahmed I., Martin, Robert C. G., Scoggins, Charles Raben, Schmidt, Carl Richard, Beal, Eliza W, Hatzaras, Ioannis, Shenoy, Rivfka, Maithel, Shishir Kumar, Shen, Perry |
| author_sort | mogal, harveshp |
| container_issue | 4_suppl |
| container_start_page | 326 |
| container_title | Journal of Clinical Oncology |
| container_volume | 34 |
| description | <jats:p> 326 </jats:p><jats:p> Background: Perioperative and long-term outcomes of patients with Hilar cholangiocarcinoma (HC) and preoperative hyperbilirubinemia have not been clearly defined. Methods: Patients with HC undergoing hepatectomy with a complete (R0/R1) resection between 2000 and 2014 were identified within a 10-institution prospectively maintained database. Using receiver operating characteristic curves from logistic regression models, a peak bilirubin cutoff point that minimized the difference between the sensitivity and specificity, was determined. Factors affecting perioperative complications were estimated using logistic regression. Results: 191 of 328 (58.2%) patients who underwent complete resection with a hepatectomy, with available preoperative bilirubin data were analyzed. 37.2% (n = 71) had bilirubin > 7.9. Patients with higher preoperative bilirubin were more likely to have a higher CA 19-9 (1776±3721.5 vs 302.1±518.6, p = 0.0006), more comorbidities (1.6±0.8 vs 1.4±0.9; p = 0.002), preoperative biliary drainage (PBD) (91.4% vs 75.6%, p = 0.007), positive lymph nodes (48.5% vs 31.5%, p = 0.025) and perioperative death (14.5% vs 5.2%, p = 0.0292). Multivariate analysis identified PBD (OR 3.2, CI 1.4-7.5; p = 0.008) and smoking (OR 2.3, CI 1.2-4.4; p = 0.016) to be independent predictors of any and major complications. Peak bilirubin > 7.9 (OR 3.1, CI 1.1-8.9; p = 0.04) and preoperative systemic sepsis (PSS) (OR 5.0, CI 1.2-21.5; p = 0.03) were associated with increased risk of postoperative mortality. However, on multivariate analysis only PSS was significant (OR 14.4, CI 2.2-93.9; p = 0.005); 5/13 (23.1%) of patients with PSS died within 30 days after surgery. Conclusions: PSS portends increased operative mortality in HC patients undergoing hepatectomy, independent of preoperative peak bilirubin levels. Prevention and aggressive treatment of PSS should be the priority in the preoperative optimization of these patients. </jats:p> |
| doi_str_mv | 10.1200/jco.2016.34.4_suppl.326 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNi4zNC40X3N1cHBsLjMyNg |
| imprint | American Society of Clinical Oncology (ASCO), 2016 |
| imprint_str_mv | American Society of Clinical Oncology (ASCO), 2016 |
| institution | DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15 |
| issn | 0732-183X, 1527-7755 |
| issn_str_mv | 0732-183X, 1527-7755 |
| language | English |
| last_indexed | 2024-03-01T12:50:52.614Z |
| match_str | mogal2016effectofpreoperativebilirubinonoutcomesofcompletelyresectedhilarcholangiocarcinomaamultiinstitutionalanalysis |
| mega_collection | American Society of Clinical Oncology (ASCO) (CrossRef) |
| physical | 326-326 |
| publishDate | 2016 |
| publishDateSort | 2016 |
| publisher | American Society of Clinical Oncology (ASCO) |
| record_format | ai |
| recordtype | ai |
| series | Journal of Clinical Oncology |
| source_id | 49 |
| spelling | Mogal, Harveshp Dodson, Rebecca Fino, Nora Ethun, Cecilia Grace Pawlik, Timothy M. Poultsides, George A. Tran, Thuy Idrees, Kamran Fields, Ryan C. Jin, Linda Weber, Sharon M. Salem, Ahmed I. Martin, Robert C. G. Scoggins, Charles Raben Schmidt, Carl Richard Beal, Eliza W Hatzaras, Ioannis Shenoy, Rivfka Maithel, Shishir Kumar Shen, Perry 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2016.34.4_suppl.326 <jats:p> 326 </jats:p><jats:p> Background: Perioperative and long-term outcomes of patients with Hilar cholangiocarcinoma (HC) and preoperative hyperbilirubinemia have not been clearly defined. Methods: Patients with HC undergoing hepatectomy with a complete (R0/R1) resection between 2000 and 2014 were identified within a 10-institution prospectively maintained database. Using receiver operating characteristic curves from logistic regression models, a peak bilirubin cutoff point that minimized the difference between the sensitivity and specificity, was determined. Factors affecting perioperative complications were estimated using logistic regression. Results: 191 of 328 (58.2%) patients who underwent complete resection with a hepatectomy, with available preoperative bilirubin data were analyzed. 37.2% (n = 71) had bilirubin > 7.9. Patients with higher preoperative bilirubin were more likely to have a higher CA 19-9 (1776±3721.5 vs 302.1±518.6, p = 0.0006), more comorbidities (1.6±0.8 vs 1.4±0.9; p = 0.002), preoperative biliary drainage (PBD) (91.4% vs 75.6%, p = 0.007), positive lymph nodes (48.5% vs 31.5%, p = 0.025) and perioperative death (14.5% vs 5.2%, p = 0.0292). Multivariate analysis identified PBD (OR 3.2, CI 1.4-7.5; p = 0.008) and smoking (OR 2.3, CI 1.2-4.4; p = 0.016) to be independent predictors of any and major complications. Peak bilirubin > 7.9 (OR 3.1, CI 1.1-8.9; p = 0.04) and preoperative systemic sepsis (PSS) (OR 5.0, CI 1.2-21.5; p = 0.03) were associated with increased risk of postoperative mortality. However, on multivariate analysis only PSS was significant (OR 14.4, CI 2.2-93.9; p = 0.005); 5/13 (23.1%) of patients with PSS died within 30 days after surgery. Conclusions: PSS portends increased operative mortality in HC patients undergoing hepatectomy, independent of preoperative peak bilirubin levels. Prevention and aggressive treatment of PSS should be the priority in the preoperative optimization of these patients. </jats:p> Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. Journal of Clinical Oncology |
| spellingShingle | Mogal, Harveshp, Dodson, Rebecca, Fino, Nora, Ethun, Cecilia Grace, Pawlik, Timothy M., Poultsides, George A., Tran, Thuy, Idrees, Kamran, Fields, Ryan C., Jin, Linda, Weber, Sharon M., Salem, Ahmed I., Martin, Robert C. G., Scoggins, Charles Raben, Schmidt, Carl Richard, Beal, Eliza W, Hatzaras, Ioannis, Shenoy, Rivfka, Maithel, Shishir Kumar, Shen, Perry, Journal of Clinical Oncology, Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis., Cancer Research, Oncology |
| title | Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. |
| title_full | Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. |
| title_fullStr | Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. |
| title_full_unstemmed | Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. |
| title_short | Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. |
| title_sort | effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: a multi-institutional analysis. |
| title_unstemmed | Effect of preoperative bilirubin on outcomes of completely resected hilar cholangiocarcinoma: A multi-institutional analysis. |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1200/jco.2016.34.4_suppl.326 |